Traders See Bearish Options Activity CVS Health Corp

 Traders See Bearish Options Activity CVS Health Corp

In today’s session CVS Health Corp (CVS) recorded an unusually high (757) contracts volume of put trades. Someone, most probably a professional was a very active buyer of the January, 2017 put, expecting serious CVS decrease. With 757 contracts traded and 24204 open interest for the Jan, 17 contract, it seems this is a quite bearish bet. The option with symbol: CVS170120P00082500 closed last at: $4.55 or 42.2% up. About 1.45 million shares traded hands. CVS Health Corp (NYSE:CVS) has declined 20.23% since April 5, 2016 and is downtrending. It has underperformed by 22.18% the S&P500.

CVS Health Corp (NYSE:CVS) Ratings Coverage

Out of 15 analysts covering CVS Health (NYSE:CVS), 11 rate it a “Buy”, 0 “Sell”, while 4 “Hold”. This means 73% are positive. $132 is the highest target while $104 is the lowest. The $116.27 average target is 39.41% above today’s ($83.4) stock price. CVS Health has been the topic of 22 analyst reports since July 22, 2015 according to StockzIntelligence Inc. The stock of CVS Health Corp (NYSE:CVS) has “Outperform” rating given on Wednesday, August 5 by RBC Capital Markets. On Monday, August 24 the stock rating was upgraded by Vetr to “Buy”. The stock has “Equal-Weight” rating given by Morgan Stanley on Monday, June 20. Evercore reinitiated the shares of CVS in a report on Wednesday, August 19 with “Buy” rating. On Thursday, December 17 the stock rating was maintained by Oppenheimer with “Outperform”. The rating was maintained by S&P Research with “Strong Buy” on Monday, November 2. The stock of CVS Health Corp (NYSE:CVS) earned “Outperform” rating by Oppenheimer on Monday, November 2. Oppenheimer maintained the shares of CVS in a report on Friday, August 28 with “Outperform” rating. Deutsche Bank maintained the stock with “Hold” rating in Wednesday, July 22 report. The stock of CVS Health Corp (NYSE:CVS) earned “Overweight” rating by Barclays Capital on Thursday, March 10.

According to Zacks Investment Research, “CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.”

Insitutional Activity: The institutional sentiment decreased to 1 in Q2 2016. Its down 0.10, from 1.1 in 2016Q1. The ratio worsened, as 67 funds sold all CVS Health Corp shares owned while 574 reduced positions. 97 funds bought stakes while 544 increased positions. They now own 833.68 million shares or 6.91% less from 895.55 million shares in 2016Q1.
Dubuque Bank & Trust Trust Company has 59,785 shares for 1.11% of their US portfolio. Front Barnett Associates Limited Company, a Illinois-based fund reported 49,497 shares. California Pub Employees Retirement reported 2.91M shares or 0.45% of all its holdings. Zevin Asset Mgmt Lc accumulated 4.84% or 182,152 shares. Ironsides Asset Advisors Limited Liability Corp owns 6,849 shares or 0.2% of their US portfolio. City Holding last reported 10,850 shares in the company. Boston Prtn owns 3.02 million shares or 0.42% of their US portfolio. Legg Mason Asset Mngmt (Japan) owns 5,200 shares or 0.54% of their US portfolio. Delta Lloyd Nv reported 74,253 shares or 0.24% of all its holdings. First National Bank, a Illinois-based fund reported 106,590 shares. Liberty Mutual Asset Mngmt owns 77,623 shares or 0.27% of their US portfolio. Somerville Kurt F accumulated 212,640 shares or 4.57% of the stock. Ingalls & Snyder Limited Liability reported 5,430 shares or 0.03% of all its holdings. American Intl Grp holds 373,197 shares or 0% of its portfolio. Beaumont Fincl Partners Limited Liability Corp accumulated 0.95% or 60,312 shares.

CVS Health Corporation, together with its subsidiaries , is a pharmacy company. The company has a market cap of $88.92 billion. The Firm operates through three business divisions: Pharmacy Services, Retail/LTC and Corporate. It has a 19.19 P/E ratio. The Firm offers a range of services and products, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare.

CVS Company Profile

CVS Health Corporation, incorporated on August 22, 1996, together with its subsidiaries (CVS Health), is a pharmacy company. The Firm operates through three business divisions: Pharmacy Services, Retail/LTC and Corporate. The Firm offers a range of services and products, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare. The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions. The Retail Pharmacy segment includes retail drugstores, online retail pharmacy Websites and its retail healthcare clinics.

More notable recent CVS Health Corp (NYSE:CVS) news were published by: Prnewswire.com which released: “CVS Health Corporation To Hold Third Quarter 2016 Conference Call” on October 28, 2016, also Fool.com with their article: “Better Buy: CVS Health Corporation vs. Walgreens Boots Alliance” published on October 11, 2016, Forbes.com published: “Ex-Dividend Reminder: CVS Health, Bard and AAR” on October 18, 2016. More interesting news about CVS Health Corp (NYSE:CVS) were released by: Seekingalpha.com and their article: “Why I Am Now Interested In CVS Health Corporation” published on October 13, 2016 as well as Seekingalpha.com‘s news article titled: “CVS Health Corporation: Attractively Valued And Set Up For Double Digit Returns” with publication date: October 19, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Tags: , ,

Related posts

Leave a Comment